MTBC Medical Transcription Billing Corp

MTBC Acquires Meridian Medical Management, a Former GE Healthcare IT Company

MTBC Acquires Meridian Medical Management, a Former GE Healthcare IT Company

Largest Acquisition to Date

SOMERSET, N.J., June 17, 2020 (GLOBE NEWSWIRE) -- -- (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, today announced the closing of its acquisition of Meridian Medical Management (“Meridian”), a former GE Healthcare IT company that delivers advanced healthcare information technology solutions and services to thousands of healthcare providers nationwide.

“Meridian is our largest acquisition to date,” said Stephen Snyder, CEO of MTBC. “We expect to provide increased revenue guidance as part of our second quarter investors call as a result of this transaction. We also believe that Meridian’s team, digital assets, and customer base will help further accelerate our growth and margin expansion during 2021 and beyond.”

Robotic Process Automation (RPA) solution leverages digital assistants called “Microbots” that replace mundane, repetitive processes, allowing organization scalability and increased production in a HIPAA-compliant environment. Meridian’s digital assets also include cloud-based business intelligence software, which provides sophisticated analysis and reporting capabilities to large, complex, multi-specialty physician groups, prestigious healthcare systems, and national healthcare IT vendors. These technology solutions are further extended by Meridian’s leading revenue cycle management and electronic health records solutions.

“Meridian’s technology will further elevate MTBC’s robust solutions with additional tools to help our customers scale and increase profitability,” said A. Hadi Chaudhry, President of MTBC. “We’re excited to welcome our new team members and customers to the MTBC family of companies.”

In the five years since its IPO, MTBC’s revenue achieved a 35% compound annual growth rate (“CAGR”) and management reaffirmed its full-year 2020 guidance in May, which would represent year-over-year revenue growth of 55 - 58% in 2020. During its Q2 earnings call, management will provide an update on its Meridian transaction, including an anticipated increase in its full-year 2020 revenue guidance.

Meridian Billing Management, Co., a Vermont corporation, was known as GE Healthcare Strategic Sourcing Corp. prior to being acquired by Gores Meridian Medical Holdings, LLC in 2013. Meridian employs more than 200 team members and maintains offices throughout the U.S., including Hartford, Connecticut, Seattle, Washington, Rutherford, New Jersey, Reading, Pennsylvania, and Hutchinson, Kansas.

MTBC acquired Meridian Billing Management and its affiliate, Origin Healthcare Solutions and subsidiaries (together, “Meridian Medical Management”), on June 16, 2020, through the closing of a stock purchase agreement. This does not purport to be a full overview of the transaction, additional information regarding which can be found in MTBC’s Form 8-K, which was filed today with the United States Securities Exchange and Commission.

B. Riley FBR, Inc. acted as exclusive investment banker to Meridian in connection with the transaction. Crosstree acted as advisors to MTBC in connection with the transaction.

About MTBC

MTBC is a healthcare information technology company that provides a full suite of proprietary cloud-based solutions, together with related business services, to healthcare providers and hospitals throughout the United States. Our Software-as-a-Service (or SaaS) platform includes revenue cycle management (RCM), practice management (PM), electronic health record (EHR), telehealth and patient experience management (PXM) solutions for high-performance medical groups. MTBC helps clients increase financial and operational performance, streamline clinical workflows, and make better business and clinical decisions, allowing them to improve patient care while reducing administrative burdens and operating costs. MTBC’s common stock trades on the Nasdaq Global Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the Nasdaq Global Market under the ticker symbol “MTBCP.”

For additional information, please visit our website at . To view MTBC's latest investor presentation, read press releases, and listen to interviews with management, please visit .

Follow MTBC on  and .

SOURCE MTBC

Forward Looking Statement

This press release contains various forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “should,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other comparable terminology.

We cannot provide any assurances that the transaction described in this press release will be consummated, or that if consummated, it will be consummated on the terms as described in this press release.

Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of the COVID-19 pandemic on our financial performance and business activities, and the expected results from the integration of our acquisitions.

These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission. In addition, there is uncertainty about the spread of the COVID-19 virus and the impact it may have on the Company’s operations, the demand for the Company’s services, and economic activity in general.

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

Company Contact:

Bill Korn

Chief Financial Officer

MTBC, Inc.

Investor Contact:

Matt Kreps

Managing Director

Darrow Associates Investor Relations







Media Inquiries:

Mike Cuesta

Chief Marketing Officer

MTBC, Inc.

EN
17/06/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medical Transcription Billing Corp

 PRESS RELEASE

CareCloud Launches AI-Driven, Fully Integrated Dermatology EHR to Stre...

CareCloud Launches AI-Driven, Fully Integrated Dermatology EHR to Streamline Workflows and Enhance Patient Care SOMERSET, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, today announced the launch of its fully integrated, AI-driven dermatology EHR, designed to streamline clinical workflows and collections, while enhancing patient engagement and improving financial outcomes for dermatology practices. "Our fully integrated, AI-dri...

 PRESS RELEASE

CareCloud to Announce Second Quarter 2025 Results on August 5, 2025

CareCloud to Announce Second Quarter 2025 Results on August 5, 2025 SOMERSET, N.J., July 16, 2025 (GLOBE NEWSWIRE) --  (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the second quarter ended June 30, 2025 before the market opens on Tuesday, August 5, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation s...

 PRESS RELEASE

CareCloud Emerges as a Top Gainer in Russell Microcap Index for Q2 202...

CareCloud Emerges as a Top Gainer in Russell Microcap Index for Q2 2025 with 70% Quarterly Increase SOMERSET, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced that its common stock rose approximately 70% during the second quarter of 2025, making it among the top gainers in the Russell Microcap® Index for the period. The Company was officially added to the Russell Microcap Index effective June 30, 2025, following the annual recon...

 PRESS RELEASE

CareCloud Joins Russell Microcap Index as Common Stock Price Rises 70%...

CareCloud Joins Russell Microcap Index as Common Stock Price Rises 70% During Q2 2025 SOMERSET, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced that it has been added to the Russell Microcap® Index, effective at the open of U.S. markets on June 30, 2025, as part of the Russell indexes’ annual reconstitution based on market capitalization, public float, and related criteria. The inclusion underscores growing...

 PRESS RELEASE

CareCloud Confirms ICFR Attestation Requirement Following $85.1 Millio...

CareCloud Confirms ICFR Attestation Requirement Following $85.1 Million Public Float Milestone; Launches Audit Firm Search SOMERSET, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced that it has surpassed the accelerated filer threshold with a public float of $85.1 million as of the market close on June 30, 2025. This achievement triggers a new compliance benchmark under SEC regulations—specifically, the incl...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch